Thirty Years of BRCA1/2 research: what have we learned?
Thirty Years of BRCA1/2 research: what have we learned?
Speaker: William D. Foulkes MD, MBBSÂ
Medical Geneticist Division Director, Medical Genetics, MUHC and JGH Chair, Department of Human Genetics, º«¹úÂãÎè
At the end of the presentation, the audience will:
Revisiting Revascularisation Strategies
Revisiting Revascularisation Strategies
Speaker: Dr. Elvin Kedhi, MD, PhD Chief of Interventional Cardiology, º«¹úÂãÎè Health Center Royal Victoria Hospital Professor of Medicine at º«¹úÂãÎè
At the end of the presentation, the audience will:
Will focus on new insights that might change the way we perform revascularisation and also pre-clinical pathways¸é´Ç´Ç³¾:Ìý¶Ù02.1312
Quality Improvement Initiatives in Radiation Oncology: 360 evaluations and beyond
Quality Improvement Initiatives in Radiation Oncology: 360 evaluations and beyond
Speaker: Dr. Tarek Hijal Director, Radiation Oncology, º«¹úÂãÎè; President, PULSE 360 Program
Co-presenter Mr. Larry Harmon Â
At the end of the presentation, the audience will: